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Timely ubiquitin-mediated protein degradation is fundamental to cell cycle control, but the precise degradation
order at each cell cycle phase transition is still unclear. We investigated the degradation order among substrates of a
single human E3 ubiquitin ligase, CRL4Cdt2, which mediates the S-phase degradation of key cell cycle proteins,
including Cdt1, PR-Set7, and p21. Our analysis of synchronized cells and asynchronously proliferating live single
cells revealed a consistent order of replication-coupled destruction during both S-phase entry and DNA repair; Cdt1
is destroyed first, whereas p21 destruction is always substantially later than that of Cdt1. These differences are at-
tributable to the CRL4Cdt2 targeting motif known as the PIP degron, which binds DNA-loaded proliferating cell
nuclear antigen (PCNADNA) and recruits CRL4Cdt2. Fusing Cdt1’s PIP degron to p21 causes p21 to be destroyed
nearly concurrently with Cdt1 rather than consecutively. This accelerated degradation conferred by the Cdt1 PIP
degron is accompanied by more effective Cdt2 recruitment by Cdt1 even though p21 has higher affinity for
PCNADNA. Importantly, cells with artificially accelerated p21 degradation display evidence of stalled replication
inmid-S phase and sensitivity to replication arrest.We therefore propose that sequential degradation ensures orderly
S-phase progression to avoid replication stress and genome instability.
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A key regulatory mechanism ensuring unidirectional pro-
gression through the eukaryotic cell division cycle is the
timely destruction of proteins via the ubiquitin–protea-
some pathway. The precise control of ubiquitin-mediated
proteolysis is critical to many cellular processes, includ-
ing transcription, DNA replication, DNA repair, and chro-
mosome segregation. Deregulated protein ubiquitylation
can promote aberrant cell proliferation and genome insta-
bility (for review, see Nakayama and Nakayama 2006;
Teixeira and Reed 2013). Ubiquitin-mediated degradation
requires the selection of a protein substrate by an E3 ubiq-
uitin ligase. Several E3 enzymes recognize their targets
via an amino acid-binding motif in the substrate called a
“degron.” For the cullin family of E3 ligases, degron bind-
ing facilitates ubiquitin transfer from an associated E2 en-
zyme to the substrate; successive ubiquitylations direct
ultimate degradation by the 26S proteasome (Petroski
and Deshaies 2005; Nakayama and Nakayama 2006).
Selectivity and timing of E3 ligase action by regulating
degron recognition or E3 ligase activity allow oscillations
in protein abundance to control key events.
It is generally presumed that an individual E3 ubiquitin
ligase targets its cohort of substrates simultaneously,
leading to their near-synchronous degradation. Counter-
ing this notion, however, several substrates of the ana-
phase-promoting complex/cyclosome (APC/C), the E3
ubiquitin ligase complex regulating mitotic progression,
are degraded sequentially. Mammalian APC/CCdc20 trig-
gers the degradation of substrates such as Nek2A and Cy-
clin A in prometaphase, well before the destruction of
other APC/C substrates like securin and Cyclin B, which
occurs during metaphase (Elzen and Pines 2001; Hagting
et al. 2002). The mechanism distinguishing early versus
late substrates involves spindle assembly checkpoint-
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driven changes in how the Cdc20 substrate adapter inter-
acts with APC (Izawa and Pines 2011). Likewise, budding
yeast APC/C directs the degradation of the mitotic cyclin
Clb5 before securin; in this instance, the distinguishing
mechanism involves cyclin-dependent kinase 1 (Cdk1)-
mediated substrate phosphorylation near a Cdc20-binding
motif (Lu et al. 2014). The ordered degradation of thesemi-
totic proteins is essential for coordinated and accuratemi-
totic progression and cytokinesis (Elzen and Pines 2001;
Lindon and Pines 2004; Izawa and Pines 2011; Lu et al.
2014). It is not yet knownwhether similar patterns of deg-
radation occur at other cell cycle transitions. In particular,
the temporal regulation of protein degradation during
S-phase entry is still poorly understood. We hypothesized
that the events of S-phase onset must be highly temporal-
ly controlled to properly coordinate replication onset,
S-phase progression, and precise genome duplication.
To test this idea, we investigated substrates of the
CRL4Cdt2 E3 ubiquitin ligase, which triggers replication-
coupled destruction of several lynchpin cell cycle proteins
during S phase. In human cells, these substrates include
Cdt1 (Arias and Walter 2005; Nishitani et al. 2006; Senga
et al. 2006) and PR-Set7 (Abbas et al. 2010; Centore et al.
2010; Oda et al. 2010; Jørgensen et al. 2011), two factors
critical to DNA replication origin licensing; the S-phase
CDK inhibitor p21 (Abbas et al. 2008; Nishitani et al.
2008); the DNA polymerase δ subunit p12 (Terai et al.
2013; Zhang et al. 2013; Zhao et al. 2014); the base exci-
sion repair enzyme thymineDNA glycosylase (TDG) (Shi-
bata et al. 2014; Slenn et al. 2014); and the nucleotide
excision repair endonuclease xeroderma pigmentosum
group G (XPG) (Han et al. 2014). Each of these proteins
is degraded by the same general mechanism, which in-
volves DNA loading of the sliding clamp processivity fac-
tor proliferating cell nuclear antigen (PCNA) during DNA
synthesis followed by binding of the substrate to DNA-
loaded PCNA (PCNADNA) via a PCNA-interacting motif
known as a PIP box (Fig. 1A; Arias andWalter 2006; Senga
et al. 2006). PIP boxes that confer replication-coupled de-
struction reside in specialized motifs termed PIP degrons
that include additional residues necessary for recognition
by CRL4Cdt2 (Havens and Walter 2009). The Cdt2 sub-
strate adaptor subunit of CRL4Cdt2 recognizes a presumed
composite surface consisting of the substrate PIP degron
and specific residues from PCNADNA (Arias and Walter
2006; Havens andWalter 2009; Havens et al. 2012). Impor-
tantly, Cdt2 cannot stimulate substrate ubiquitylation
unless the substrate is first bound to PCNADNA, a require-
ment that couples substrate destruction directly to DNA
synthesis (Havens and Walter 2009). Perturbations to rep-
lication-coupled destruction have profound effects on
S-phase progression and genome stability (Arias and Wal-
ter 2005, 2006; Abbas et al. 2010; Centore et al. 2010; Oda
et al. 2010; Tardat et al. 2010; Terai et al. 2013; Zhang
et al. 2013; Shibata et al. 2014).
The cell cycle functions of CRL4Cdt2 substrates vary
widely, raising the possibility that theymay need to be de-
graded at different times relative to one another to ensure
Figure 1. CRL4Cdt2 substrates are degraded in
a stereotypical order during early S phase. (A)
The mechanism of cell cycle regulation of
CRL4Cdt2 substrates requires PCNA DNA
loading. (B) HCT116 cells were synchronized
by sequential thymidine and nocodazole treat-
ment and fixed at 2.5 h (G1) or 4 h (early S) after
nocodazole release. Cells were labeled with
bromodeoxyuridine (BrdU) 30 min prior to fix-
ation and staining with the indicated antibod-
ies. Bar, 5 μm. (C ) Average fluorescence
intensities relative to G1 from three indepen-
dent experiments. n = 15. (D) Percentage of nu-
clei positively stained by anti-Cdt1 or anti-p21.
n = 650. (E) Percentage of nuclei positively
staining with the indicated antibodies from
three independent experiments. n = 200. Error
bars indicate standard deviations.
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orderly transition from G1 to S phase. Although the mo-
lecular mechanism of CRL4Cdt2-mediated degradation is
well characterized, it is still unclearwhether all substrates
are degraded with similar timing. It is also unclear wheth-
er the relative timing of substrate destruction is important
for the proper coordination of S-phase progression. In this
study, we provide the first direct evidence of ordered sub-
strate degradation of CRL4Cdt2 substrates and show that
the timing of substrate degradation is related to differenc-
es in the substrates’ PIP degron affinities for Cdt2. The
sequential rather than simultaneous degradation pattern
is essential to avoid replication stress during S phase.
Results
CRL4Cdt2 substrates are degraded
sequentially during early S phase
We first determined whether two CRL4Cdt2 substrates
are degraded simultaneously or in a specified order at
the G1/S transition. Toward that end, we quantified the
change in Cdt1 and p21 concentrations in individual
late G1-phase versus early S-phase cells. We synchronized
HCT116 cells in mitosis by sequential thymidine and
nocodazole blocks (Chandrasekaran et al. 2011), released
them from nocodazole, and pulse-labeled them with bro-
modeoxyuridine (BrdU) prior to harvesting at time points
corresponding to either G1 (2.5 h after release) or early S
phase (4 h after release). We then immunostained these
cells for endogenous Cdt1, p21, and BrdU incorporation.
Both Cdt1 and p21 were readily detectable in G1, but, no-
tably, Cdt1wasmostly degraded by early S phase, whereas
p21 was not (Fig. 1B); p21 was more fully degraded later in
S (Supplemental Fig. 1) We quantified the mean nuclear
fluorescence intensities (Fig. 1C) and scored nuclei for
Cdt1 or p21 (Fig. 1D). In cells with detectable Cdt1 or
p21, the concentrationofCdt1decreased>10-fold between
G1 (2.5 h) and early S phase (4 h), but p21 levels decreased
only twofold during that same time period (Fig. 1C). Fur-
thermore, far fewer nuclei retained Cdt1 at the early
S-phase time point (24%) than retained p21 (70%). More-
over, we detected a relatively low occurrence of BrdU-pos-
itive cells that costained for Cdt1 (9%), whereas BrdU/p21
double-positive cells were much more prevalent (30% of
the total and nearly half of the BrdU-positive cells), sug-
gesting that cells initiate DNA replication in the presence
of p21 (Fig. 1E).Wenote that, at this single time point after
synchronization, not all cells have yet entered S-phase,
which contributes to the Cdt1-positive cells in Figure 1D.
A potential caveat to these immunofluorescence exper-
iments was that the detection of endogenous Cdt1 and
p21 required the use of different antibodies. To directly
compare the rates of Cdt1 and p21 degradation using the
same detectionmethod, we generated fluorescent fusions.
We fused cyan fluorescent protein (CFP; “mCerulean3”)
to the C terminus of Cdt1 and yellow fluorescent protein
(YFP; “Venus”) to the N terminus of p21 bearing a nuclear
localization signal (NLS); these arrangements leave the re-
gions of each protein that direct replication-coupled de-
struction unperturbed. We expressed them from a single
bicistronic mRNA in which the two fusions were separat-
ed by a viral self-cleaving sequence from porcine teschovi-
rus “P2A” (Fig. 2A; Kim et al. 2011). We integrated the
bicistronic cassette into U2OS cells at a single FRT locus
under control of a doxycycline-inducible promoter; the
parent cells were engineered to constitutively express a
histone H2B-mCherry fusion. Addition of doxycycline to
the culture medium resulted in a dose-dependent induc-
tion of both fusions, and, importantly, no uncleaved pro-
tein was detectable even at the highest concentrations
(Fig. 2A). Induction with 20 ng/mL doxycycline produced
YFP-p21 at close to endogenous levels, and Cdt1-CFP was
moderately overproduced, so we selected this concentra-
tion for subsequent experiments (Fig. 2A, lane 3). Impor-
tantly, both fusions showed the same stability as their
endogenous counterparts (Supplemental Fig. 2A,B), and
much higher levels of expressionwere required to produce
detectable cell cycle perturbations (Supplemental Fig.
2C–E). Based on our immunostaining results (Fig. 1), we
predicted that Cdt1-CFP would be consistently degraded
before YFP-p21 and that, in asynchronous populations,
we would observe YFP single-positive cells but few CFP
single-positive cells. To test this prediction, we imaged
fixed asynchronous, unperturbed cells by fluorescence
microscopy (Fig. 2B). We identified nuclei and scored
them as either YFP (p21)-positive, CFP (Cdt1)-positive,
double-positive, or double-negative. Among cells with
detectable fluorescence expression, double positives were
the most abundant class, representing cells presumed
to be in either G1 or G2 phase (31%). (Of note, we did
not achieve 100% expression under these induction con-
ditions, meaning that we cannot conclude that all dou-
ble-negative nuclei are in S phase.) Strikingly, however,
YFP-p21 single positives represented a significant subpo-
pulation (22%), whereas Cdt1-CFP single positives were
exceedingly rare (0.3%) (Fig. 2C). Altogether, these results
suggest that the CRL4Cdt2 substrates Cdt1 and p21 under-
go sequential rather than simultaneous degradation upon
S-phase entry during an unperturbed cell cycle. This find-
ing prompted investigation into the molecular mecha-
nism of this differential targeting.
CRL4Cdt2 substrates are degraded sequentially
during DNA repair synthesis
Since most DNA repair processes involve a DNA synthe-
sis step, PCNA is loaded during DNA repair, similar to its
DNA loading during S phase. Consequently, CRL4Cdt2
substrates are also degraded during DNA repair (Senga
et al. 2006; Abbas et al. 2008, 2010; Nishitani et al.
2008; ). We took advantage of this knowledge to induce
synchronous PCNA loading and therefore simultaneous
and robust replication-coupled destruction in otherwise
asynchronous populations. We employed a semiquanti-
tative immunoblotting strategy to compare the relative
degradation kinetics duringDNA repair for CRL4Cdt2 sub-
strates (Materials andMethods; Supplemental Fig. 3A). To
determine whether CRL4Cdt2-mediated destruction also
occurs sequentially during DNA repair, we irradiated
HCT116 cells with 20 J/m2 UV and monitored levels of
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three CRL4Cdt2 targets—Cdt1, PR-Set7, and p21—in a
time course. Similar to our analysis of theG1/S transition,
Cdt1 was degraded dramatically faster than p21. By
15min post-irradiation, Cdt1 was already >50% degraded,
but p21 persisted much longer and was not substantially
degraded until 60–120 min post-irradiation (Fig. 3A, cf.
lanes 2,5 and lane 1). The half-life of Cdt1 was only 9
min, but p21 was degraded with an average half-life of
53 min; the half-time for PR-Set7 degradation was inter-
mediate at 23 min (Fig. 3A). Importantly, we observed
the same sequential relationship among the CRL4Cdt2
substrates using other damaging agents such as oxidative
damage (Fig. 3B) and the radiomimetic bleocin (data not
shown). Moreover, the degradation order was similar in
other cell lines, including immortalized primary fibro-
blasts (NHF-hTERT) and U2OS cells (Fig. 3C).
We also observed the same relative degradation order in
cycloheximide-treated cells (Supplemental Fig. 3B) and
that p21 stably expressed from a heterologous promoter
was degraded with the same kinetics as endogenous p21
(Fig. 4A; Supplemental Fig. 3B). These observations elim-
inated the possibility that the particularly slow p21 degra-
dation reflected a contribution from p53-dependent p21
induction. We note that p21 is a well-known DNA dam-
age-inducible gene, making the degradation of p21 protein
after DNA damage somewhat counterintuitive. p21 in-
duction and cell cycle arrest typically occur at lower doses
and much later time points after DNA damage (Pagano
et al. 1994; Bendjennat et al. 2003); in agreement with
these previous studies, we also observed that p21 induc-
tion and cell cycle arrest only occurred 24 h after we treat-
edHCT116 cells with 2–5 J/m2UV (Supplemental Fig. 3C,
D). On the other hand, CRL4Cdt2-mediated p21 destruc-
tion within 2–3 h was the predominant response to the
higher doses of UV (20 J/m2) used throughout this study.
HeLa cells that are functionally p53-deficient also degrad-
ed Cdt1more rapidly than they degraded PR-Set7 (Supple-
mental Fig. 3E). A recent study implicated the tripartite
motif 39 (TRIM39) protein in regulating p21 degradation
by blocking Cdt2 binding and inhibiting p21 degradation
(Zhang et al. 2012). We tested a mutant form of p21 that
fails to bind TRIM39 described in that study (p21-
K153A) but observed no appreciable acceleration in its
rate of degradation compared with the wild-type version
(Supplemental Fig. 3F). Thus, we determined that slow
p21 degradation is common to many human cell lines
andmust be via amechanismunrelated to de novo protein
synthesis or interaction with TRIM39.
The Cdt1 PIP degron confers an
accelerated degradation rate
Human Cdt1 codons 1–28 encode its single PIP degron,
and,when fused to a heterologous substrate, this sequence
is sufficient to confer CRL4Cdt2-mediated degradation
(Senga et al. 2006; Rizzardi et al. 2014). Given our finding
Figure 2. Cdt1-CFP is degraded more rapidly than YFP-p21 in unperturbed cells. (A, top) Schematic of the bicistronic expression con-
struct; Cdt1-HA-mCerulean3 (CFP) and Venus (YFP)-HA-p21 are produced from a singlemRNAdue to the presence of a viral self-cleaving
peptide, “2A.” (Bottom) The resulting Cdt1 and p21 fusions were expressed from a single FRT locus in U2OS cells after doxycycline in-
duction with the indicated concentrations for 20 h. The arrowmarks the concentration used for imaging, and the asterisk marks the pre-
dicted size of the fusion in the absence of 2A-mediated cleavage. (B) A representative field showing double-negative, double-positive, and
YFP (Venus) single-positive cells; four single-positive cells aremarked with arrowheads. Bar, 100 µM. (C ) Quantification of asynchronous
Cdt1-mCerulean3-expressing and Venus-p21expressing U2OS cells. Averages from three fields of cells (n > 150 per field) were scored as
double-negative, double-positive, or single-positive.
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thatCdt1 is consistently themost rapidly degraded among
the CRL4Cdt2 substrates tested, we sought to determine
whether the Cdt1 PIP degron is sufficient to confer the
fast kinetics of degradation. We therefore fused Cdt1 1–
28 to the N terminus of an epitope-tagged p21 and com-
pared this fusion with a correspondingly epitope-tagged
wild-type p21.We generated stable HCT116 cell lines pro-
ducing these fusions at near-endogenous levels and used
the same UV irradiation strategy to induce synchronous
replication-coupled destruction as in Figure 3. First, the
addition of an N-terminal HA epitope tag to p21 had no
measureable effect on degradation kinetics; both endoge-
nous and tagged p21 were degraded at the same rate and
substantially slower than endogenous Cdt1 (Fig. 4A). Sec-
ond, constitutive expression of HA-p21 from a heterolo-
gous promoter had no effect on p21 degradation kinetics
(Fig. 4A; Supplemental Fig. 3B) and did not alter cell cycle
phase distribution (Supplemental Fig. 3C [lane 6], D).
Strikingly however, the PIPCdt1-p21 chimerawas degraded
much more rapidly than either wild-type p21 or endoge-
nous p21, and this chimeric protein more closely resem-
bled the degradation kinetics of endogenous Cdt1 with a
half-life of just 20 min (Fig. 4B). A PIPCdt1-p21 chimera
inwhich key amino acids of the Cdt1 PIP degronweremu-
tated to alanine (PIPmCdt1-p21) was degraded with kinet-
ics similar to both wild-type HA-p21 and endogenous
p21, as expected (Fig. 4C). Thus, addition of the Cdt1
PIP degron to the N terminus of p21 is sufficient to confer
accelerated p21 degradation.
We considered several explanations for the rapid degra-
dation of the PIPCdt1-p21 fusion: the addition of a second
PIP degron, the N-terminal location of the PIP degron, or
the PIP degron sequence itself. To test the idea that rapid
degradation is achieved simply by the presence of two
degrons, we disrupted the native p21 PIP degron sequence
in the PIPCdt1-p21 chimera, leaving only the one Cdt1 PIP
degron,“PIPCdt1-p21PIPm.”We confirmed p21 PIP degron
impairment in a control experiment (Supplemental Fig.
4A,B). The PIPCdt1-p21PIPm fusionwas still degraded fast-
er than endogenous p21 (Fig. 4D), indicating that the pres-
ence of two degron sequences did not account for the
accelerated degradation of the PIPCdt1-p21 fusion in Figure
4B. The native PIP degron sequences of Cdt1 and p21 are
located at either the N or C terminus of each protein, re-
spectively; thus, the relative location of the PIP degrons
could impact accessibility to PCNA and/or CRL4Cdt2. Im-
portantly, when we fused a second copy of p21’s PIP
degron to its own N terminus, this PIPp21-p21 fusion
was degraded slowly, like endogenous p21 (Fig. 4E). Final-
ly, we fused the p21 PIP degron to an HA-tagged form of
Cdt1 lacking its own native PIP degron. We confirmed
that the tag did not disrupt wild-type Cdt1 degradation ki-
netics (Fig. 4F) and that deleting Cdt1’s PIP degron stabi-
lized Cdt1 independently (Supplemental Fig. 4C). Cdt1
bearing a single PIP degron derived from p21was degraded
more slowly than wild-type Cdt1, particularly at later
time points (Fig. 4F). These experiments yielded several
important mechanistic insights: The PIP degron sequence
itself carries intrinsic and transferable information dictat-
ing the degradationkinetics, the location of the PIP degron
sequence has little impact on degradation kinetics, and an
additional PIP degron sequence is insufficient to enhance
the degradation rate.
The accelerated degradation of the PIPCdt1-p21 fusion
during DNA repair suggested that a similar fusion would
be degraded with faster kinetics in early S phase, since
the same ubiquitylation pathway applies to both S phase
and DNA repair. To test that idea, we fused YFP to the
C terminus of PIPCdt1-containing p21 and integrated this
doxycycline-inducible fusion into U2OS cells expressing
histone H2B-mCherry. As a control, we integrated a
YFP-p21 fusion to create a separate cell line. (The arrange-
ment of these fusions was designed to avoid perturbing
the relevant PIP degrons.) Of note, high concentrations
of doxycycline induced substantial p21 overproduction
and G1 accumulation, indicating that both fusions are
likely active CDK inhibitors (Supplemental Fig. 5A,B),
but cells can tolerate moderate p21 overproduction (e.g.,
from induction with 10–30 ng/mL) with no detectable
change in cell cycle phase distribution (Supplemental
Fig. 5B). Moreover, the UV-triggered degradation of
PIPCdt1-p21-YFP was accelerated compared with normal
Figure 3. CRL4Cdt2 substrates are degraded
sequentially during DNA repair synthesis.
HCT116 cells were treated with 20 J/m2 UV
(A) or 100 μM tert-butyl peroxide (B) and har-
vested at the indicated times after treatment
for immunoblot analysis. Nonspecific bands
serving as loading controls are indicated by as-
terisks. Quantifications of immunoblots from
a minimum of three biological replicates of
the UV time course are plotted. (C ) NHF-
hTERT cells (lanes 1–7) or U2OS cells (lanes
8–14) were treated with 20 J/m2 UV and har-
vested at the indicated time points as in A. Er-
ror bars indicate standard error of the mean
(SEM).
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YFP-p21 or endogenous p21 similar to the HA-tagged fu-
sions in Figure 4B (Supplemental Fig. 5C).
We induced expression of both p21 fusions to similar
levels (10 ng/mL for wild-type and 30 ng/mL for PIPCdt1-
p21) and imaged unperturbed proliferating cells for at least
16 h, capturing fluorescence images of histone H2B-
mCherry and YFP-p21 every 10 min (see representative
Supplemental Movies 1,2). We subjected the videos to
computational segmentation using the histone H2B-
mCherry tomark and track nuclei and then automatically
quantified the average fluorescence intensity of YFP in
both lines (see the Materials and Methods). Each set of
Figure 4. The Cdt1 PIP degron confers accelerated degradation to p21 during DNA repair. (A) HCT116 cell lines were generated that sta-
bly produce HA-tagged wild-type p21 (A), HA-tagged PIPCdt1-p21 (B), HA-tagged PIPmCdt1-p21 bearing inactivatingmutations in the Cdt1
PIP degron (C ), an HA-tagged PIPCdt1-p21 fusion with the native p21 PIP degron inactivated (D), or PIPp21-p21 with the native p21 PIP
degron added to the N terminus (E). (F ) HA-tagged wild-type Cdt1 or Cdt1 lacking its native PIP degron (“Δ”) but fused to the p21 PIP
degron was expressed from an inducible promoter in U2OS cells with 20 ng/mL doxycycline. These cell populations were treated with
20 J/m2 UV and harvested at the indicated times for immunoblot analysis. Quantifications of immunoblots for ectopic and endogenous
p21 and Cdt1 proteins are from two independent experiments. Error bars indicate SEM.
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fluorescence intensities was normalized from 0 (mini-
mum) to 1 (maximum) for 50 cells that we selected for ex-
pression of the fusion and that underwent both mitosis
and a complete degradation/reaccumulation cycle (i.e.,
S phase) within the recorded time. The dynamics of
YFP-p21 degradation are shown for these cells as a heat
map in Figure 5A, with the first data point plotted for
each cell corresponding to the video frame containing
the cell division that produced that cell. Fitting these in
silico aligned traces for each cell to an inverse sigmoidal
curve yielded Td, the time from mitosis to the half-point
of degradation (Fig. 5B). We then calculated the relative
maximal rates of degradation from the slopes at each Td
and noted that the degradation rate of the PIPCdt1-contain-
ing fusion was more than five times that of the fusion
bearing only the native p21 PIP degron.
Differential recruitment of PCNA/Cdt2 by PIP degrons
Wenext generated new degron fusions in which either the
Cdt1 or p21 PIP degron plus a NLS was fused to glutathi-
one-S-transferase (GST). These fusions created an artifi-
cial substrate for replication-coupled CRL4Cdt2-mediated
proteolysis and had the added benefit of isolating the
Cdt1 and p21 PIP degrons from their respective full-length
proteins (Fig. 6A). We monitored the degradation kinetics
of theGST fusions afterUV irradiation as before and found
that PIPp21-GST was degraded more slowly than PIPCdt1-
GST, similar to the relationship between the endogenous
proteins from which they were derived (Fig. 6A).
Two critical interactions for productive replication-
coupled destruction are binding of the PIP degron to
PCNADNA and subsequent recruitment of CRL4 through
substrate interaction with the substrate receptor Cdt2.
Differences in affinities for PCNADNA and/or Cdt2 could
explain why proteins containing the Cdt1 PIP degron are
consistently degraded before proteins with the p21 PIP
degron. To test this idea, we produced the same PIPCdt1-
GST and PIPp21-GST constructs in bacteria, isolated the
recombinant proteins on glutathione beads, and used
them to retrieve PCNADNA andCdt2 from sonicated chro-
matin fractions of human cell lysates. We had previously
used this strategy to analyze interactions of full-length
Cdt1 with PCNADNA and Cdt2 (Chandrasekaran et al.
2011). As controls, we included a full-length GST-tagged
p21 and a PIP mutant form of p21 that cannot bind
PCNA, PIPmp21-GST (Rizzardi et al. 2014). As expected,
the PIP mutant p21, unlike the wild-type p21, did not
bind PCNADNA (Supplemental Fig. 6).
First, although equal amounts of solubilized chromatin
were incubated with the two PIP degron fusions, the p21
PIP degron retrieved approximately three times more
PCNA than the Cdt1 PIP degron did under the same con-
ditions (Fig. 6B, cf. lanes 3 and 4). This tight binding of p21
to PCNA is consistent with prior studies (Gulbis et al.
1996; Arias and Walter 2006). Surprisingly, even with
this strong relative binding to PCNA, the p21 PIP degron
did not recruit proportionately more Cdt2 (Fig. 6B, cf.
lanes 3 and 4). In fact, PIPCdt1-GST retrieved more Cdt2
than PIPp21-GST did despite holding threefold less
PCNADNA (Fig. 6B, lanes 3,4). The significantly better
Cdt2 binding with PIPCdt1 GSTwasmost readily apparent
when we directly compared equal levels of copurified
PCNA; PIPCdt1-GST bound more than fivefold more
Cdt2 than PIPp21-GST did for the same amount of copuri-
fied PCNA (Fig. 6C,D, lanes 3,4). Thus, the Cdt1 PIP
degron more efficiently recruits Cdt2, and this effect like-
ly contributes to its accelerated degradation via the
CRL4Cdt2 E3 ubiquitin ligase.
We also considered a potential role for ubiquitin E2 uti-
lization in the differential degradation of Cdt1 and p21.
Ubiquitylation by cullin E3 ligases is catalyzed by
Figure 5. The Cdt1 PIP degron confers accel-
erated degradation to p21 at G1/S. (A) Heat
maps for the kinetics of YFP-p21 and PIPCdt1-
p21-YFP degradation in 50 asynchronously
proliferating cells generated by high-content
live-cell imaging. Expression was induced
with 30 ng/mL doxycycline for wild-type
YFP-p21 and 10 ng/mL doxycycline for
PIPCdt1-p21-YFP (see Supplemental Fig. 5),
and individual cell fluorescence intensity trac-
eswere computationally aligned tomitosis (t =
0). Fluorescence intensities were normalized
to individualminima andmaxima (see theMa-
terials and Methods). (B) Data were fit to sig-
moidal curves, and the average time for
degradation frommitosis to the half minimum
fluorescence intensity, Td, is marked with
black dashed lines on both the heat maps and
the plots. The slopes at Td are indicated.
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associated E2 ubiquitin-conjugating enzymes (UBCs), and
our recent study showed that ubiquitylation of p21 and
Cdt1 is carried out by different E2s: UBE2G1 +UBE2G2
for Cdt1 and UBCH8 for p21 (Shibata et al. 2011). Differ-
ent E2s may be responsible for the different degradation
rates, and, furthermore, exchanging the PIP degronsmight
have led to E2 switching. To test this hypothesis, we used
RNAi-mediated depletion of the relevant E2s to deter-
mine whether the PIPCdt1-p21 fusion (diagramed in Fig.
4B) relies on the E2 that normally targets Cdt1 (i.e.,
UBE2G1 +UBE2G2). As shown in Supplemental Figure
7, A and B, however, the PIPCdt1-p21 fusion, just like en-
dogenous p21, was stabilized in UBCH8-depleted cells,
whereas its typical accelerated degradation pattern was
observed in both control andUBE2G1 +UBE2G2-depleted
cells. Thus, we concluded that degradation of PIPCdt1-p21
still involves the same E2 as normal p21, arguing against
an E2 switch. Substrate features separate from those
directly responsible for E3 recruitment must control E2
specificity, but that discrimination plays little role in
the rate of CRL4Cdt2-mediated degradation.
Delayed p21 degradation facilitates
normal S-phase progression
We next sought to probe the physiological importance of
sequential CRL4Cdt2 substrate degradation. Specifically,
we tested the consequences of imposing the early Cdt1
degradation pattern on p21. For this purpose, we stably
produced siRNA-resistant versions of the PIPCdt1-p21
and wild-type p21 described in Figure 4 in HCT116 cells.
We depleted endogenous p21 and analyzed cell cycle pro-
files by flow cytometric measurement of BrdU incorpora-
tion and DNA content (Fig. 7A). Neither siRNA depletion
of p21 nor stable expression of wild-type p21 had a sub-
stantial effect on overall cell cycle distribution in these
cells (Fig. 7B), but we noted that p21 depletion caused an
increase in a subpopulation of cells of intermediate
DNA content (i.e., S phase) that were not actively synthe-
sizing DNA. We scored this population as “BrdUneg/S
phase,” and, following p21 depletion, there were three
times more BrdUneg/S-phase cells compared with control
cells. This phenotypewas complemented by ectopic wild-
type p21 (without causing cell cycle arrest), but, striking-
ly, PIPCdt1-p21 cells still generated the BrdUneg/S-phase
subpopulation (Fig. 7A,B). PIPCdt1-p21 was produced at
levels similar to endogenous p21 in control RNA-treated
cells, which suggests that the phenotype of the PIPCdt1-
p21 line is the kinetics of p21 degradation rather than in-
sufficient p21 (Fig. 7C).
The increase in cells that reached mid-S phase but then
stopped DNA synthesis (BrdUneg/S phase) suggested that
premature p21 degradation leads to difficulty inmaintain-
ing active replication. If true, then these cells may experi-
ence higher than normal rates of endogenous DNA
damage, which could render themmore sensitive to addi-
tional damage or replication stress. To test that idea more
directly, we produced the same p21 fusions as YFP-tagged
forms (i.e., Fig. 5) in U2OS cells and then challenged them
to recover from a strong replication block.We depleted en-
dogenous p21 (Supplemental Fig. 8A) and then held cells
in hydroxyurea (HU) for 16 h to induce replication stall-
ing. We immunostained for a marker of DNA damage of-
ten associated with replication stress, γ-H2AX, and found
the expected high percentage of positively staining cells in
all HU-arrested populations (Fig. 7D,E). Releasing cells
into fresh medium allowed S-phase resumption within
12 h in cells expressing normal p21 as measured by both
flow cytometry (Supplemental Fig. 8B) and elimination
Figure 6. TheCdt1 PIP degron bindsmoreCdt2 than the p21 PIP
degron. (A) HCT116 cells stably expressing either Cdt1 PIP
(amino acids 1–28) or p21 PIP (amino acids 137–164) fused to
the N terminus of GST were UV-treated and harvested for im-
munoblot analysis at the indicated times. (B) PIP-GST fusion
proteinswere purified from Escherichia coli lysateswith glutathi-
one-sepharose beads and incubated with sonicated chromatin
fractions from UV-irradiated 293T cells. Bound proteins were
eluted in 2× SDS buffer and subjected to immunoblot analysis
with the indicated antibodies. Lanes 2–4 contained equivalent
amounts of GST fusions. (C ) PIP degron-bound proteins were pre-
pared as in B but loaded equivalently for copurified PCNA. (D)
Quantification of the relative amounts of bound PCNA and
Cdt2, based on two independent experiments. Error bars indicate
standard deviations.
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of γ-H2AX foci (Fig. 7D,E). In contrast to both siRNA con-
trols and p21-depleted cells complemented with wild-
type p21, however, p21 depletion caused twofold more re-
tention of γ-H2AX signal 12 h after HU release (Fig. 7D [12
h], E). Strikingly, cells expressing PIPCdt1-p21 to levels
similar to wild-type p21 (Supplemental Fig. 8A) retained
as much γ-H2AX signal as p21-depleted cells did (Fig.
7C,D). Altogether, these results indicate that the normal
delayed p21 degradation in early S phase contributes to ro-
bust replication progression during S phase. Furthermore,
the absence of p21 during early S phase sensitizes cells to
subsequent replication stress and DNA damage.
Discussion
In this study, we provide conclusive evidence that, despite
being subject to the same targeting mechanism, several
substrates of theCRL4Cdt2 E3ubiquitin ligase aredegraded
in a conserved and stereotypical order. In particular, p21
degradation is significantly delayed relative to Cdt1 (and
PR-Set7) duringboth early Sphase andDNArepair.As a re-
sult, early S-phase cells and cells beginning DNA repair
lackCdt1butstillhaveabundantp21.Severalotherstudies
(Bendjennat et al. 2003; Abbas et al. 2008, 2010; Nishitani
et al. 2008; Shibata et al. 2011; Zhang et al. 2013) explored
CRL4Cdt2 substrate degradation kinetics, and late p21
degradation is detectable in those studies but had not
been investigated. We note also that these three proteins
appear to reaccumulate at the end of S phase in reverse or-
der relative to the order inwhich they are degraded (Nishi-
tani et al. 2008; Abbas et al. 2010; Rizzardi et al. 2014).
Based on our observations, early Cdt1 degradation rela-
tive to p21 in S phase is likely due to differences in the ef-
ficiency with which different PIP degrons recruit Cdt2
(Fig. 8A). It is not yet clear, however, why the Cdt1 PIP
degron confers weaker PCNA binding but more efficient
Cdt2 recruitment. Detailed structural information about
the interaction of p21’s PIP degronwith PCNA is available
(Gulbis et al. 1996), and a collection of alanine substitu-
tions at sites critical for PCNA binding or Cdt2 recruit-
ment block replication-coupled destruction (Arias and
Walter 2006; Havens and Walter 2009). Interestingly,
however, none of those previously studied positions are
significantly different between the p21 and Cdt1 PIP
degrons (Supplemental Fig. 4B). We presume that the
substantially more efficient in vitro Cdt2 recruitment by
the Cdt1 PIP degron is the major reason for faster Cdt1
degradation in vivo, but other mechanisms may also con-
tribute. Among these factors are differences in ubiquityla-
tion processivity, as is observed among substrates of the
APC/C (Rape et al. 2006). Strikingly, p21’s PIP degron
binds PCNADNA in vitro more efficiently than Cdt1’s
PIP degron does (Fig. 6). It is possible that the p21–
Figure 7. Accelerating p21 degradation pro-
motes replication stress. (A) Asynchronously
growing HCT116 cell lines stably expressing
the indicated HA-tagged p21 fusions were
treated with 100 nM control or p21 siRNA
for 48 h. Cells were labeled for 1 h with BrdU
and analyzed by flow cytometry with anti-
BrdU antibody to detect DNA synthesis
(Y-axis) and with propidium iodide for DNA
content (X-axis). Flow cytometry gating for dis-
tinguishing BrdU-negative S-phase cells is in-
dicated in the schematic. The percentage of
the total population in each gated cell cycle
phase is indicated on the plots. (B) The percent-
age of BrdU-negative/S-phase cells in samples
from B. Error bars indicate SEM. (C ) Immuno-
blots of endogenous and ectopic p21 in B. (D)
U2OS cells producing the indicated p21-YFP
fusions (induced with 10 ng/mL doxycycline)
were treated with 2 mM hydroxyurea (HU)
for 16 h and subsequently released into fresh
medium for 12 h, as indicated. (D) Representa-
tive images show γ-H2AX staining of cells for
each condition. The percentage of γ-H2AX-
positive cells is quantified in E. Bar, 30 μm.
For quantifications, >200 nuclei from ran-
domly selected fields were counted for each
condition, and error bars represent standard
deviations from two independent experi-
ments. P = <0.05.
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PCNADNA interaction is in fact too tight formaximally ef-
ficient degradation compared with other CRL4Cdt2 sub-
strates, but this idea has not yet been explored. Tight
PCNA binding by p21 has been suggested to compete
with other PCNA-binding proteins (Warbrick et al.
1997; Ducoux et al. 2001; Arias and Walter 2006), and so
we considered the possibility that competition among
PIP degrons contributes to their order of degradation.
However, we did not observe any evidence for competi-
tion effects either at the endogenous levels of CRL4Cdt2
substrates or when they are moderately overproduced.
For example, the approximately twofold increase in PIP
degrons from the ectopic fusions in Figure 4, A and B,
had no effect on the rates of endogenousCdt1 and p21 deg-
radation. Thus, we do not favor amodel inwhich the high-
er affinity of Cdt2 for Cdt1 leads to slower p21 degradation
strictly through competition for either PCNA or Cdt2.
By fusingCdt1’s PIP degron to p21,we created a scenario
in which p21 is expressed in G1 but degraded prematurely
at the beginning of S phase rather than at the normal time
well after S phase is under way. Interestingly, the conse-
quences of accelerating the timing of p21 degradation are
very similar to depleting cells of p21 altogether with re-
spect to replication stress. The striking similarity of cells
expressing the PIPCdt1-p21 fusion to p21-depleted cells in-
dicates that a critical period for p21 expression is early S
phase, since PIPCdt1-p21 cells have sufficient p21 in G1.
Cells lacking p21 in early S showed both an increase in
theproportionofcells that failedSphaseandareducedabil-
ity to recover from a strong replication block. Particularly
with respect to the increase in BrdUneg/S-phase cells, we
were initially surprised to observe what appeared to be a
mid-to-late S-phase phenotype, since mid-S-phase cells
have already degraded p21. In addition, the recovery from
an HU block seems unrelated to the degradation rates of
the p21 fusions during the arrest, since both are degraded
at 0 h. However, we consider that these phenotypes are a
downstream consequence of insufficient p21 in early
Sphase, leadingtooverallhigher levelsofendogenousdam-
age prior to or during the HU block and a longer recovery
time. Even in the absence of HU treatment, we observed
a small (although not statistically significant) increase in
γ-H2AX-positive proliferating cells expressing only the
prematurely degraded p21 (data not shown). The combina-
tionof pre-existing replication stresswith anHUchallenge
couldaccount for thepoor recovery fromreplicationarrest.
Our findings suggest a model for the need to degrade
Cdt1 at the very beginning of S phase but delay p21 degra-
dation until later in S phase (Fig. 8B). In normal cells, Cdk2
activity begins to rise in late G1 due to the increase in cy-
clin E, but p21 is still present (Fig. 1). Once S phase begins
and PCNA is loaded at early-firing origins, the continued
presence of p21 restrains S-phase progression by slowing
the rise of Cdk2 activity. In this model, early S-phase cells
have lower totalCdk2 activity thanmid-S cells, but the in-
termediate Cdk2 activity supports some origin firing and
PCNA loading. During this early S-phase period, Cdt1 is
rapidly degraded to prevent origin relicensing and rerepli-
cation. This rapid degradation may be particularly impor-
tant because two of the blocks to rereplication, the
geminin inhibitor protein and cyclin A, are lower in early
S phase than when they reach maximal levels later in
S (Girard et al. 1991; Rosenblatt et al. 1992; Wohlschlegel
et al. 2000). If p21 is degraded prematurely, Cdk2 activity
may rise too early, leading to more origins firing at the be-
ginning of S phase than normally should and subsequent
replication stress. In support of that notion,manipulations
in both yeast and Xenopus laevis experimental systems
that shift origin firing towards early S phase induce replica-
tion stress markers (Gibson et al. 2004; Woodward et al.
2006; Mantiero et al. 2011). Replication fork speed may
also be affected by p21 tightly bound to PCNA (Waga
et al. 1994). The aggregate of effects such as these may ex-
plain the higher likelihood of S-phase failure in cells that
prematurely degrade p21. We therefore conclude that
some key molecular events at the G1/S transition must
happen in a defined order to ensure a normal S-phase pro-
gression. These findings raise the possibility thatmany as-
pects of cell cycle transitions are alsoprogrammedtooccur
in a stereotypical sequence to ensure genome stability.
Materials and methods
Cell culture and manipulations
HCT116 and HEK 293T cells were obtained fromAmerican Type
Culture Collection and cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Sigma) supplemented with 10% fetal calf
Figure 8. Model. (A)Despite lowerbindingaffinity forPCNA,the
Cdt1 PIP degron recruitsmoreCdt2 than the p21 PIP degron does.
(B) The normal relatively delayed degradation of p21 by CLR4Cdt2
permits only intermediate Cdk2 activity in early S phase rather
thanmaximalactivityatS-phaseonset.Themoregradualdegrada-
tion of p21 prevents replication stress (see the Discussion).
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serum (Sigma). U2OSTRex cells were a gift from JohnAster (Mal-
ecki et al. 2006). NHF-hTert cells are normal human fibroblasts
immortalized with telomerase. HCT116 cells were synchronized
in prometaphase by treatment with 2mM thymidine for 18 h fol-
lowed by release into 100 nM nocodazole. To obtain populations
of cells in either G1 or early S phase, cells were released from the
prometaphase arrest by mitotic shake-off, replated in complete
medium, and collected at either 2.5 h (G1) or 4 h (early S phase).
To arrest replication forks and measure recovery, U2OS cells ex-
pressing empty vector, wild-type p21, or PIPCdt1-p21 were treated
with 2 mMHU for 16 h and released into fresh medium. UV irra-
diation experimentswere performed using a single dose of 20 J/m2
in a Stratalinker (Stratagene). AdditionalDNAdamage repair trig-
gers used were 100 µM tert-butyl peroxide (Sigma) and 10 µg/mL
bleocin (EMD Millipore). Lentiviral packaging was performed
by standard protocols in 293T cells followed by infection and
selection of HCT116 cells with 1 µg/mL puromycin. Synthe-
tic duplexed RNA oligonucleotides were synthesized by Life
Technologies: Luciferase (5′-CUUACGCUGAGUACUUCGA-3′),
p21-2 (5′-AACAUACUGGCCUGGACUGUU-3′), UBCH8 (5′-GC
AAGAACCAGAAAGAGAA-3′), UBE2G1 (5′-GGGAAGAUAAG
UAUGGUUA-3′), andUBE2G2 (5′-UGACGAAAGUGGAGCUA
AC-3′). Significance testingused the two-tailed Student’s t-test on
at least three biological replicates.
Antibodies
Antibodies were purchased from the following sources: p21,
PCNA, and anti-HA from Santa Cruz Biotechnology; PR-Set7
and Cdt1 from Cell Signaling Technologies; α-tubulin, GAPDH,
and GST from Sigma; anti-BrdU from BD Biosciences; anti-phos-
pho-Histone H2A.X (Ser139) from EMD Millipore; anti-HA from
Roche Life Sciences; anti-UBCH8 and anti-UBE2G1 from Protein
Tech; and anti-UBE2G2 from Thermo Scientific. Antibodies
to human Cdt1 (Cook et al. 2004) and Cdt2 (Abbas et al. 2008)
have been described previously. Alexa fluor 488, Rhodamine
Red-X, and Cy5 donkey secondary antibodies for immunofluores-
cence microscopy were obtained from Jackson ImmunoResearch
Laboratories.
Plasmids and recombinant protein preparation
For expression in mammalian cells, wild-type p21, PIPCdt1-p21,
PIPCdt1-GST, PIPp21-GST, wild-type Cdt1 bearing an HA epitope
tag, Cdt1 15-546-HA (“ΔPIP”), and PIPp21-Cdt1-HA alleles were
subcloned into pENTR vectors and subsequently transferred
into a retroviral vector, pQCXIP CMV TO/DEST (Addgene,
17386) (Campeau et al. 2009), to pDESTJC16 or pDESTJC17 by
Gateway cloning. The K153A mutation in p21 was generated
through site-directed mutagenesis. Lentiviral PIPmCdt1-p21,
PIPCdt1-p21PIPm, PIPp21-p21, and PIPm-p21 plasmidswere gener-
ated by subcloning cDNAs into a pCDH IRES mcherry vector
(System Biosciences). pBabe-puro-H2B-mCherry was subcloned
fromPGK-H2B-mCherry (gift fromMarkMercola; Addgene, plas-
mid no. 21217) into pBabe-puro using standard methods.
pDESTJC16 and pDESTJC17 are derivatives of pcDNA5/FRT/
TO-Venus-Flag-Gateway (gift from Jonathon Pines; Addgene,
plasmid 40999) in which the hygromycin resistance gene has
been replaced with either the puromycin or the nourseothricin re-
sistance gene, respectively, using standard methods. pEXP-
JC17-Cdt1-mCerulean3-P2A-Venus-NLS-p21, pEXP-JC17-2HN-
Venus, and pEXP-JC17-Venus-NLS-p21 were generated by Gate-
way cloning from pENTR vectors. Both Venus and mCerulean3
fluorophores were selected for their relative brightness and rapid
fluorescence maturation. Plasmids for expressing wild-type and
PIPm-p21 GST fusions were generated by recombinational Gate-
way cloning (LR Clonase, Invitrogen) between pENTR plasmids
and pDEST15. Additional plasmids for PIPCdt1-GST and PIPp21-
GST fusions were constructed by subcloning cDNAs into
pET11b vector (Novagen). The PIP mutants were generated by
site-directedmutagenesis to introduce alanine codons a positions
corresponding to Cdt1 amino acids 5–8 or p21 amino acids 146–
150. PIP degron fusions carried human Cdt1 amino acids 1–28 or
human p21 amino acids 137–164. GST fusions were transformed
into BL21 (DE3) cells (Invitrogen) and partially purified as de-
scribed previously (Cook et al. 2004).
Protein lysate preparation
Whole-cell lysates were prepared by direct lysis of equal cell num-
bers in either 2× Laemmli sample buffer with 10% β-mercaptoe-
thanol or CSK buffer (Cook et al. 2002) supplemented with 0.1%
TritonX-100 and protease and phosphatase inhibitors. Densitom-
etry analysis of immunoblots of lysates was performed using Na-
tional Institutes ofHealth ImageJ software (normalized to tubulin
expression). At least two film exposures were chosen for quanti-
fications of each protein analyzed such that one lane of each ex-
posure was of equal band intensity and thereby served as a
normalization control. Quantifications represent percentages of
each protein remaining relative to the starting amount prior to
UV irradiation (time = 0 min). Half-lives were estimated from
semi-log plots of the ln (percentage remaining) versus time.
GST pull-down assays
The recombinant GST fusion proteins described above were im-
mobilized on glutathione-sepharose 4B resin (GE Healthcare).
UV-irradiated HEK293T cells were lysed in CSK buffer (supple-
mented with 0.1% Triton X-100 plus protease and phosphatase
inhibitors). Chromatin fractionswere prepared as described previ-
ously (Cook et al. 2002) and subjected to low-power sonication of
Triton-insoluble pellets to fragment DNA-bound material. Solu-
ble chromatin fractions were clarified by centrifugation at
13,000g for 15 min at 4°C and incubated with bound GST fusion
proteins for 3 h with rotation at 4°C. Beads were washed three
times in supplemented CSK buffer, and bound proteins were elut-
ed by boiling for 5 min in 40 μL of 2× SDS sample buffer.
Immunofluorescence microscopy
HCT116 cells synchronized in either G1 or early S phase were
pulse-labeled with 50 µM BrdU for 30 min prior to fixation in
2% paraformaldehyde for 15 min. DNA was denatured with
1.5 N hydrochloric acid for 15 min. Cells were permeabilized
with 0.5% Triton-X-100 for 5 min and then blocked in 0.1%
BSA for 1 h. Incubations with primary and fluorescent secondary
antibodieswere performed in 0.1%BSA for 1 h at 37°C, andwash-
es were for 10 min at room temperature. DAPI (4′,6-diamidino-2-
phenylindole) staining (0.1 µg/mL) was performed for 10min, and
cells were mounted using Prolong Gold anti-fade reagent (Life
Technologies/Molecular Probes).
For indirect immunofluorescencemicroscopy, images were ac-
quired using Velocity software and a 60×/1.42 NA (PlanApo) DIC
oil immersion objective mounted on a Olympus 1X81 inverted
microscope equipped with a Hamamatsu Orca ER cooled CCD
camera. For fluorescence intensity measurements, the average
values for integrated nuclearCdt1 and p21 fluorescence fromcon-
trol and experimental cell samples were subjected to background
subtraction to obtain the specific nuclear fluorescence levels.
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Flow cytometry analysis
Cells to be analyzed by flow cytometry were labeled with 10 μM
BrdU for 1 h prior to trypsinization and fixation in 70% ethanol.
Nuclei were stained with anti-BrdU antibody (BD Biosciences)
followed by Alexa fluor 488-labeled secondary antibody (Jackson
ImmunoResearch Laboratories) and were counterstained with
propidium iodide. Flow cytometry analysis was performed using
aCyan FACScan (DakoCytomation) and Summit version 4.3 soft-
ware (DakoCytomation).
Fixed-cell imaging analysis
Asynchronous U2OS cells expressing Cdt1-mCerulean3-P2A-
Venus-p21 induced with 20 ng/mL doxycycline were fixed with
2% paraformaldehyde using standard methods and imaged on a
Nikon Ti Eclipse inverted microscope running NIS Elements
software version 4.30.02 with an Andor ZYLA 4.2 camera using
a 20× objective. Images of randomly selected fields were collected
in all three channels (CFP, YFP, and RFP) using exposure times
producing approximately equivalent nuclear fluorescence in the
three channels. ImageJ (version 1.49p) was used to identify nuclei
on the H2B-mCherry images using the nucleus counter plug-in
from the ImageJ Cookbook. Cells were scored for Venus and/or
mCerulean3 expression over three randomly selected fields
(n > 150 per field).
Live-cell imaging analysis
Asynchronous U2OS cells stably expressing histone H2B-
mCherry and PIPCdt1-p21-Venus or Venus-NLS-p21 were plated
on 35-mm glass-bottom plates (Cellvis) in imagingmedium (phe-
nol-red-freeDMEM [Invitrogen] supplementedwith 10%FBS and
1× pennicillin/streptomycin) ∼24 h before being imaged. Cells
were imaged for a minimum of 18 h using a Nikon Ti Eclipse mi-
croscope operated byNIS Elements software version 4.30.02 with
an Andor ZYLA 4.2 camera and a custom stage enclosure to en-
sure constant temperature, humidity, and CO2 levels. Protein ex-
pression was induced with 10 ng/mL (PIPCdt1-p21), or 30 ng/mL
(Ven-NLS-p21) doxycycline 20 h before imaging. Fresh medium
with doxycycline was added 5 h before imaging. Images were
flat-field-corrected using NIS Elements. Fifty cells of each line
were selected for analysis based on Venus expression and visual-
ization of a complete cycle (minimum mitosis to S-phase
degradation).
Single-cell fluorescence intensity was quantified using custom
MATLAB software, which is available on request. In each frame,
the nuclei of individual cells were identified using an adaptive
threshold followed by watershed segmentation of the H2B-
mCherry channel. Cells were tracked through consecutive
frames by tracking nearest nuclear centroids between frames.
The resulting nuclear borders were used to quantify average fluo-
rescence intensity from other channels (e.g., p21-Venus). Missing
time points, which were generally no more than one to two
frames, were interpolated linearly. To compare the decay kinetics
of individual cells, fluorescence intensity was normalized be-
tween 0 and 1. The delay time, Td, was calculated by fitting
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